<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">jofin</journal-id><journal-title-group><journal-title xml:lang="ru">Журнал инфектологии</journal-title><trans-title-group xml:lang="en"><trans-title>Journal Infectology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2072-6732</issn><publisher><publisher-name>IPO “АIDSSPbR"</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.22625/2072-6732-2025-17-4-35-50</article-id><article-id custom-type="elpub" pub-id-type="custom">jofin-1887</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Обзор</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Особенности генетической регуляции восприимчивости человека к вирусным инфекциям</article-title><trans-title-group xml:lang="en"><trans-title>Peculiarities of genetic regulation of human susceptibility to viral infections</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Вербенко</surname><given-names>Д. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Verbenko</surname><given-names>D. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Вербенко Дмитрий Анатольевич – старший научный сотрудник, к.б.н. </p><p>Екатеринбург</p></bio><bio xml:lang="en"><p>Ekaterinburg</p></bio><email xlink:type="simple">verbenko_da@niivirom.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Беляев</surname><given-names>В. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Belyaev</surname><given-names>V. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Беляев Владимир Алексеевич – лаборант </p><p>Екатеринбург</p></bio><bio xml:lang="en"><p>Ekaterinburg</p></bio><email xlink:type="simple">vova-belyaev-90@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Панова</surname><given-names>А. Е.</given-names></name><name name-style="western" xml:lang="en"><surname>Panova</surname><given-names>A. E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Панова Анна Евгеньевна – заместитель директора по научной работе, к.м.н. </p><p>Екатеринбург</p></bio><bio xml:lang="en"><p>Ekaterinburg</p></bio><email xlink:type="simple">panova_ae@niivirom.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Вашукова</surname><given-names>М. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Vashukova</surname><given-names>M. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Вашукова Мария Александровна – ассистент кафедры инфекционных болезней; заместитель главного врача, к.м.н. </p><p>Санкт-Петербург</p></bio><bio xml:lang="en"><p>Saint-Petersburg</p></bio><email xlink:type="simple">mavashukova@yahoo.com</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Семенов</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Semenov</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Семенов Александр Владимирович – директор, д.б.н. </p><p>Екатеринбург</p></bio><bio xml:lang="en"><p>Ekaterinburg</p></bio><email xlink:type="simple">semenov_av@niivirom.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Федеральный научно-исследовательский институт вирусных инфекций «Виром»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Federal Research Institute of Viral Infections ‘Virom’</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Национальный медицинский исследовательский центр им. В.А. Алмазова;&#13;
Клиническая инфекционная больница им. С.П. Боткина</institution><country>Россия</country></aff><aff xml:lang="en"><institution>National Medical Research Center named after V.A. Almazov;&#13;
Infectious Diseases Hospital named after S.P. Botkin</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>18</day><month>12</month><year>2025</year></pub-date><volume>17</volume><issue>4</issue><fpage>35</fpage><lpage>50</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Вербенко Д.А., Беляев В.А., Панова А.Е., Вашукова М.А., Семенов А.В., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Вербенко Д.А., Беляев В.А., Панова А.Е., Вашукова М.А., Семенов А.В.</copyright-holder><copyright-holder xml:lang="en">Verbenko D.A., Belyaev V.A., Panova A.E., Vashukova M.A., Semenov A.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.niidi.ru/jofin/article/view/1887">https://journal.niidi.ru/jofin/article/view/1887</self-uri><abstract><p>Функционирование генома человека играет роль в обеспечении защиты организма от вирусной инвазии. Восприимчивость организма к различным вирусным заболеваниям обусловлена не только особенностями работы систем врожденного и адаптивного иммунитета, но также индивидуальными различиями геномов. Мутации в области гена FUT2 могут оказывать протективный эффект в отношении норовирусных гастроэнтеритов, однако при этом повышают риск развития и осложненного течения других заболеваний. Молекулярный механизм взаимодействия генов семейства OAS с системой врожденного иммунитета, а также особенности нормального полиморфизма генома влияют на развитие и благоприятный исход вирусных заболеваний. Анализ источников информации взаимосвязи геномных процессов с течением и исходом вирусных заболеваний, отдельных аспектов влияния особенностей заболеваний на эти процессы проведен на июль 2025 г. по основным поисковым электронным базам данных, включая PubMed, Scopus, eLIBRARY и Google Scholar, по следующим ключевым словам: FUT, OAS, HDAC, epigenetics, immune resistance, viral diseases, host immunity. Представлены некоторые механизмы влияния эпигенетических процессов на характер течения заболеваний, а также на возможности их терапевтической коррекции. Исследование фундаментальных аспектов влияния механизмов генетического контроля на восприимчивость к вирусным инфекциям позволит сформировать новые представления о группах риска, механизмах профилактики и лечения заболеваний.</p></abstract><trans-abstract xml:lang="en"><p>The functioning of the human genome plays a role in protecting the body from viral invasion. The body’s susceptibility to various viral diseases is determined not only by the functioning of the innate and adaptive immune systems but also by individual genomic differences. Mutations in the FUT2 gene region can exert a protective effect against norovirus gastroenteritis, but also increase the risk of developing and complicating other diseases. The molecular mechanism of interaction between OAS family genes and the innate immune system, as well as the characteristics of normal genomic polymorphism, influence the development and favorable outcome of viral diseases. An analysis of information sources on the relationship between genomic processes and the course and outcome of viral diseases, as well as individual aspects of the influence of disease characteristics on these processes, was conducted as of July 2025. The following keywords were used in key electronic databases, including PubMed, Scopus, eLIBRARY, and Google Scholar: FUT, OAS, HDAC, epigenetics, immune resistance, viral diseases, and host immunity. Several mechanisms of the influence of epigenetic processes on the course of diseases, as well as the possibilities for their therapeutic correction, are presented. Research into the fundamental aspects of the influence of genetic control mechanisms on susceptibility to viral infections will allow for new understanding of risk groups and mechanisms for disease prevention and treatment.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>геном</kwd><kwd>вирусная инвазия</kwd><kwd>эпигенетика</kwd><kwd>олигоаденилатсинтаза</kwd><kwd>фукозилтрансфераза</kwd><kwd>резистентность</kwd></kwd-group><kwd-group xml:lang="en"><kwd>genome</kwd><kwd>viral invasion</kwd><kwd>epigenetics</kwd><kwd>oligoadenylate synthase</kwd><kwd>fucosyltransferase</kwd><kwd>resistance</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Исследование проведено при финансовой поддержке Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека (государственное задание на выполнение НИР рег. № 123051100045-0).</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Ameen MT, French CR. Genetic Diseases of Fucosylation: Insights from Model Organisms. Genes. 2025; 16: 800. https://doi.org/10.3390/genes16070800</mixed-citation><mixed-citation xml:lang="en">Ameen MT, French CR. Genetic Diseases of Fucosylation: Insights from Model Organisms. Genes. 2025; 16: 800. https://doi.org/10.3390/genes16070800</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Ruvoen-Clouet N, Belliot G, Le Pendu J. Noroviruses and histo-blood groups: the impact of common host genetic polymorphisms on virus transmission and evolution. Reviews in Medical Virology. 2013;23(6):355–366. https://doi.org/10.1002/rmv.1757</mixed-citation><mixed-citation xml:lang="en">Ruvoen-Clouet N, Belliot G, Le Pendu J. Noroviruses and histo-blood groups: the impact of common host genetic polymorphisms on virus transmission and evolution. Reviews in Medical Virology. 2013;23(6):355–366. https://doi.org/10.1002/rmv.1757</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Ramani S, Hu L, Venkataram Prasad BV, Estes MK. Diversity in Rotavirus-Host Glycan Interactions: A “Sweet” Spectrum. Cell Mol Gastroenterol Hepatol. 2016;2(3):263-273. https://doi.org/10.1016/j.jcmgh.2016.03.002</mixed-citation><mixed-citation xml:lang="en">Ramani S, Hu L, Venkataram Prasad BV, Estes MK. Diversity in Rotavirus-Host Glycan Interactions: A “Sweet” Spectrum. Cell Mol Gastroenterol Hepatol. 2016;2(3):263-273. https://doi.org/10.1016/j.jcmgh.2016.03.002</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Hutson AM, Atmar RL, Graham DY, Estes MK. Norwalk Virus Infection and Disease Is Associated with ABO Histo–Blood Group Type. The Journal of Infectious Diseases. 2002;185(9):1335–1337. https://doi.org//10.1086/339883</mixed-citation><mixed-citation xml:lang="en">Hutson AM, Atmar RL, Graham DY, Estes MK. Norwalk Virus Infection and Disease Is Associated with ABO Histo–Blood Group Type. The Journal of Infectious Diseases. 2002;185(9):1335–1337. https://doi.org//10.1086/339883</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Graziano VR, Wei J, Wilen CB. Norovirus Attachment and Entry. Viruses. 2019;11(6):495. https://doi.org/10.3390/v11060495</mixed-citation><mixed-citation xml:lang="en">Graziano VR, Wei J, Wilen CB. Norovirus Attachment and Entry. Viruses. 2019;11(6):495. https://doi.org/10.3390/v11060495</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Patel MM, Widdowson MA, Glass RI, et al. Systematic Literature Review of Role of Noroviruses in Sporadic Gastroenteritis. Emerging Infectious Diseases. 2008;14(8):1224–1231. https://doi.org/10.3201/eid1408.071114</mixed-citation><mixed-citation xml:lang="en">Patel MM, Widdowson MA, Glass RI, et al. Systematic Literature Review of Role of Noroviruses in Sporadic Gastroenteritis. Emerging Infectious Diseases. 2008;14(8):1224–1231. https://doi.org/10.3201/eid1408.071114</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Быков, Р.О., Семенов, А.В., Старикова, П.К. и др. Изучение аспектов формирования генетически детерминированной резистентности против возбудителя норовирусной инфекции посредством полиморфизма гена FUT2. Эпидемиология и Вакцинопрофилактика / Р.О. Быков, А.В. Семенов, П.К. Старикова // Эпид. и Вакцинопроф. – 2023. – Т.22,№6. – С. 148 – 154. https://doi.org/10.31631/2073-3046-2023-22-6-148-154</mixed-citation><mixed-citation xml:lang="en">Bykov, R.O., Semenov, A.V., Starikova, P.K. i dr. Izuchenie aspektov formirovaniya geneticheski determinirovannoj rezistentnosti protiv vozbuditelya norovirusnoj infekcii posredstvom polimorfizma gena FUT2. Ehpidemiologiya i Vakcinoprofilaktika. R.O. Bykov, A.V. Semenov, P.K. Starikova // Ehpid. i Vakcinoprof. – 2023. – Т.22,№6. – С. 148 – 154. https://doi:10.31631/2073-3046-2023-22-6-148-154</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Kaur P, Gupta M, Sagar V. FUT2 gene as a genetic susceptible marker of infectious diseases: A Review. International Journal of Molecular Epidemiology and Genetics. 2022;13(1):1-14; www.ncbi.nlm.nih.gov/pmc/articles/PMC9301175</mixed-citation><mixed-citation xml:lang="en">Kaur P, Gupta M, Sagar V. FUT2 gene as a genetic susceptible marker of infectious diseases: A Review. International Journal of Molecular Epidemiology and Genetics. 2022;13(1):1-14; www.ncbi.nlm.nih.gov/pmc/articles/PMC9301175</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Soejima M, Koda Y. Survey and characterization of nonfunctional alleles of FUT2 in a database. Sci Rep. 2021;11:3186. https://doi.org/10.1038/s41598-021-82895-w</mixed-citation><mixed-citation xml:lang="en">Soejima M, Koda Y. Survey and characterization of nonfunctional alleles of FUT2 in a database. Sci Rep. 2021;11:3186. https://doi.org/10.1038/s41598-021-82895-w</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Soejima M, Koda Y. Real-time PCR-based detection of the Alu-mediated deletion of FUT2 (sedel2). Leg Med (Tokyo) 2022;54:101986. https://doi.org/10.1016/j.legalmed.2021.101986 Epub 2021 Oct 30. PMID: 34736142.</mixed-citation><mixed-citation xml:lang="en">Soejima M, Koda Y. Real-time PCR-based detection of the Alu-mediated deletion of FUT2 (sedel2). Leg Med (Tokyo) 2022;54:101986. https://doi.org/10.1016/j.legalmed.2021.101986 Epub 2021 Oct 30. PMID: 34736142.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Soejima M, Nakajima T, Fujihara J, et al. Genetic variation of FUT2 in Ovambos, Turks, and Mongolians. Transfusion. 2008;48(7):1423–1431. https://doi.org/10.1111/j.1537-2995.2008.01710</mixed-citation><mixed-citation xml:lang="en">Soejima M, Nakajima T, Fujihara J, et al. Genetic variation of FUT2 in Ovambos, Turks, and Mongolians. Transfusion. 2008;48(7):1423–1431. https://doi.org/10.1111/j.1537-2995.2008.01710</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Iqbal MW, Ahmad M, Shahab M, Sun X, Baig MM, Yu K, Dawoud TM, Bourhia M, Dabiellil F, Zheng G, Yuan Q. Exploring deleterious non-synonymous SNPs in FUT2 gene, and implications for norovirus susceptibility and gut microbiota composition. Sci Rep. 2025;15(1):10395. https://doi.org/10.1038/s41598-025-92220-4</mixed-citation><mixed-citation xml:lang="en">Iqbal MW, Ahmad M, Shahab M, Sun X, Baig MM, Yu K, Dawoud TM, Bourhia M, Dabiellil F, Zheng G, Yuan Q. Exploring deleterious non-synonymous SNPs in FUT2 gene, and implications for norovirus susceptibility and gut microbiota composition. Sci Rep. 2025;15(1):10395. https://doi.org/10.1038/s41598-025-92220-4</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Thorven M, Grahn A, Hedlund KO, et al. A Homozygous Nonsense Mutation (428G–A) in the Human Secretor (FUT2) Gene Provides Resistance to Symptomatic Norovirus (GGII) Infections. Journal of Virology. 2005;79 (24):15351–15355. https://doi.org/10.1128/jvi.79.24.15351-15355.2005</mixed-citation><mixed-citation xml:lang="en">Thorven M, Grahn A, Hedlund KO, et al. A Homozygous Nonsense Mutation (428G–A) in the Human Secretor (FUT2) Gene Provides Resistance to Symptomatic Norovirus (GGII) Infections. Journal of Virology. 2005;79 (24):15351–15355. https://doi.org/10.1128/jvi.79.24.15351-15355.2005</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Tan M, Jin M, Xie H, et al. Outbreak studies of a GII-3 and a GII-4 norovirus revealed an association between HBGA phenotypes and viral infection. Journal of Medical Virology. 2008;80(7):1296–1301. https://doi.org/10.1002/jmv.21200</mixed-citation><mixed-citation xml:lang="en">Tan M, Jin M, Xie H, et al. Outbreak studies of a GII-3 and a GII-4 norovirus revealed an association between HBGA phenotypes and viral infection. Journal of Medical Virology. 2008;80(7):1296–1301. https://doi.org/10.1002/jmv.21200</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Jin M, He Y, Li H, et al. Two Gastroenteritis Outbreaks Caused by GII Noroviruses: Host Susceptibility and HBGA Phenotypes. Kirk M, ed. PLoS ONE. 2013;8(3):e58605. https://doi.org/10.1371/journal.pone.0058605</mixed-citation><mixed-citation xml:lang="en">Jin M, He Y, Li H, et al. Two Gastroenteritis Outbreaks Caused by GII Noroviruses: Host Susceptibility and HBGA Phenotypes. Kirk M, ed. PLoS ONE. 2013;8(3):e58605. https://doi.org/10.1371/journal.pone.0058605</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Colston JM, Francois R, Pisanic N, Peñataro YP, McCormick BJJ, Olortegui MP et al. Effects of Child and Maternal Histo-Blood Group Antigen Status on Symptomatic and Asymptomatic Enteric Infections in Early Childhood. J Infect Dis. 2019;220(1):151-162. https://doi.org/10.1093/infdis/jiz072</mixed-citation><mixed-citation xml:lang="en">Colston JM, Francois R, Pisanic N, Peñataro YP, McCormick BJJ, Olortegui MP et al. Effects of Child and Maternal Histo-Blood Group Antigen Status on Symptomatic and Asymptomatic Enteric Infections in Early Childhood. J Infect Dis. 2019;220(1):151-162. https://doi.org/10.1093/infdis/jiz072</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Giampaoli O, Conta G, Calvani R and Miccheli A. Can the FUT2 Non-secretor Phenotype Associated With Gut Microbiota Increase the Children Susceptibility for Type 1 Diabetes? A Mini Review. Front. Nutr. 2020;7:606171. https://doi.org/10.3389/fnut.2020.606171</mixed-citation><mixed-citation xml:lang="en">Giampaoli O, Conta G, Calvani R and Miccheli A. Can the FUT2 Non-secretor Phenotype Associated With Gut Microbiota Increase the Children Susceptibility for Type 1 Diabetes? A Mini Review. Front. Nutr. 2020;7:606171. https://doi.org/10.3389/fnut.2020.606171</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Trang NV, Vu HT, Le NT, et al. Association between Norovirus and Rotavirus Infection and Histo-Blood Group Antigen Types in Vietnamese Children. Journal of Clinical Microbiology. 2014;52(5):1366–1374. https://doi.org/10.1128/jcm.02927-13</mixed-citation><mixed-citation xml:lang="en">Trang NV, Vu HT, Le NT, et al. Association between Norovirus and Rotavirus Infection and Histo-Blood Group Antigen Types in Vietnamese Children. Journal of Clinical Microbiology. 2014;52(5):1366–1374. https://doi.org/10.1128/jcm.02927-13</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Imbert-Marcille BM, Barbe L, Dupe M, et al. A FUT2 Gene Common Polymorphism Determines Resistance to Rotavirus A of the P[8] Genotype. The Journal of Infectious Diseases. 2013;209(8):1227–1230. https://doi.org/10.1093/infdis/jit655</mixed-citation><mixed-citation xml:lang="en">Imbert-Marcille BM, Barbe L, Dupe M, et al. A FUT2 Gene Common Polymorphism Determines Resistance to Rotavirus A of the P[8] Genotype. The Journal of Infectious Diseases. 2013;209(8):1227–1230. https://doi.org/10.1093/infdis/jit655</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Zhernakova DV, Wang D, Liu L et al. Host genetic regulation of human gut microbial structural variation. Nature 2024;625:813–821. https://doi.org/10.1038/s41586-023-06893-w</mixed-citation><mixed-citation xml:lang="en">Zhernakova DV, Wang D, Liu L et al. Host genetic regulation of human gut microbial structural variation. Nature 2024;625:813–821. https://doi.org/10.1038/s41586-023-06893-w</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Fan R, Han X, Gong Y, He L, Xue Z, Yang Y et al. Alterations of Fucosyltransferase Genes and Fucosylated Glycans in Gastric Epithelial Cells Infected with Helicobacter pylori. Pathogens. 2021;10:168. https://doi.org/10.3390/pathogens10020168</mixed-citation><mixed-citation xml:lang="en">Fan R, Han X, Gong Y, He L, Xue Z, Yang Y et al. Alterations of Fucosyltransferase Genes and Fucosylated Glycans in Gastric Epithelial Cells Infected with Helicobacter pylori. Pathogens. 2021;10:168. https://doi.org/10.3390/pathogens10020168</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Li Q, Guo W, Qian Y, et al. Protein O-fucosyltransferase 1 promotes PD-L1 stability to drive immune evasion and directs liver cancer to immunotherapy. Journal for ImmunoTherapy of Cancer. 2024;12:e008917. https://doi.org/10.1136/ jitc-2024-008917</mixed-citation><mixed-citation xml:lang="en">Li Q, Guo W, Qian Y, et al. Protein O-fucosyltransferase 1 promotes PD-L1 stability to drive immune evasion and directs liver cancer to immunotherapy. Journal for ImmunoTherapy of Cancer. 2024;12:e008917. https://doi.org/10.1136/ jitc-2024-008917</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Ahluwalia TS, Eliasen AU, Sevelsted A et al. FUT2–ABO epistasis increases the risk of early childhood asthma and Streptococcus pneumoniae respiratory illnesses. Nat Commun. 2020;11:6398. https://doi.org/10.1038/s41467-020-19814-6</mixed-citation><mixed-citation xml:lang="en">Ahluwalia TS, Eliasen AU, Sevelsted A et al. FUT2–ABO epistasis increases the risk of early childhood asthma and Streptococcus pneumoniae respiratory illnesses. Nat Commun. 2020;11:6398. https://doi.org/10.1038/s41467-020-19814-6</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Hovanessian AG, Justesen J. The human 2’-5’oligoadenylate synthetase family: unique interferon-inducible enzymes catalyzing 2’-5’ instead of 3’-5’ phosphodiester bond formation. Biochimie. 2007;89:779–788.</mixed-citation><mixed-citation xml:lang="en">Hovanessian AG, Justesen J. The human 2’-5’oligoadenylate synthetase family: unique interferon-inducible enzymes catalyzing 2’-5’ instead of 3’-5’ phosphodiester bond formation. Biochimie. 2007;89:779–788.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Anderson BR, Muramatsu H, Jha BK, Silverman RH, Weissman D, Karikó K. Nucleoside modifications in RNA limit activation of 2’-5’-oligoadenylate synthetase and increase resistance to cleavage by RNase L. Nucleic Acids Res. 2011;39(21):9329-38. https://doi.org/10.1093/nar/gkr586</mixed-citation><mixed-citation xml:lang="en">Anderson BR, Muramatsu H, Jha BK, Silverman RH, Weissman D, Karikó K. Nucleoside modifications in RNA limit activation of 2’-5’-oligoadenylate synthetase and increase resistance to cleavage by RNase L. Nucleic Acids Res. 2011;39(21):9329-38. https://doi.org/10.1093/nar/gkr586</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Laudenbach BT. Processing of viral nucleic acids. Dissertation zur Erlangung des Doktorgrades der Fakult¨at f¨ur Chemie und Pharmazie der Ludwig-Maximilians. [Rottweil, Deutschland]:Universit¨at Munchen; 2018.</mixed-citation><mixed-citation xml:lang="en">Laudenbach BT. Processing of viral nucleic acids. Dissertation zur Erlangung des Doktorgrades der Fakult¨at f¨ur Chemie und Pharmazie der Ludwig-Maximilians. [Rottweil, Deutschland]:Universit¨at Munchen; 2018.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Choi UY, Kang JS, Hwang YS, et al. Oligoadenylate synthase-like (OASL) proteins: dual functions and associations with diseases. Exp. Mol. Med. 2015;47:e144.</mixed-citation><mixed-citation xml:lang="en">Choi UY, Kang JS, Hwang YS, et al. Oligoadenylate synthase-like (OASL) proteins: dual functions and associations with diseases. Exp. Mol. Med. 2015;47:e144.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Schwartz SL, Park EN, Vachon VK, Danzy S, Lowen AC, Conn GL. Human OAS1 activation is highly dependent on both RNA sequence and context of activating RNA motifs. Nucleic Acids Research. 2020;48(13):7520-531. https://doi.org/10.1093/nar/gkaa513</mixed-citation><mixed-citation xml:lang="en">Schwartz SL, Park EN, Vachon VK, Danzy S, Lowen AC, Conn GL. Human OAS1 activation is highly dependent on both RNA sequence and context of activating RNA motifs. Nucleic Acids Research. 2020;48(13):7520-531. https://doi.org/10.1093/nar/gkaa513</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Melchjorsen J, Kristiansen H, Christiansen R, Rintahaka J, Matikainen S, Paludan SR et al. Differential Regulation of the OASL and OAS1 Genes in Response to Viral Infections. Journal of interferon and cytokine research. 2009;29(4):199-207.</mixed-citation><mixed-citation xml:lang="en">Melchjorsen J, Kristiansen H, Christiansen R, Rintahaka J, Matikainen S, Paludan SR et al. Differential Regulation of the OASL and OAS1 Genes in Response to Viral Infections. Journal of interferon and cytokine research. 2009;29(4):199-207.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Harioudh MK, Perez J, Chong Z, Nair S, So L, McCormick KD et al. Oligoadenylate synthetase 1 displays dual antiviral mechanisms in driving translational shutdown and protecting interferon production. Immunity. 2024;57(3):446-461.e7. https://doi.org/10.1016/j.immuni.2024.02.002</mixed-citation><mixed-citation xml:lang="en">Harioudh MK, Perez J, Chong Z, Nair S, So L, McCormick KD et al. Oligoadenylate synthetase 1 displays dual antiviral mechanisms in driving translational shutdown and protecting interferon production. Immunity. 2024;57(3):446-461.e7. https://doi.org/10.1016/j.immuni.2024.02.002</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Banday AR, Stanifer ML, Florez-Vargas O, Onabajo OO, Papenberg BW, Zahoor MA, Mirabello L et al. Genetic regulation of OAS1 nonsense-mediated decay underlies association with COVID-19 hospitalization in patients of European and African ancestries. Nat Genet. 2022;54(8):1103-1116. https://doi.org/10.1038/s41588-022-01113-z</mixed-citation><mixed-citation xml:lang="en">Banday AR, Stanifer ML, Florez-Vargas O, Onabajo OO, Papenberg BW, Zahoor MA, Mirabello L et al. Genetic regulation of OAS1 nonsense-mediated decay underlies association with COVID-19 hospitalization in patients of European and African ancestries. Nat Genet. 2022;54(8):1103-1116. https://doi.org/10.1038/s41588-022-01113-z</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Iida K, Ajiro M, Nakano-Kobayashi A, Muramoto Y, Takenaga T, Denawa M, Kurosawa R, Noda T, Hagiwara M. Switching of OAS1 splicing isoforms overcomes SNP-derived vulnerability to SARS-CoV-2 infection. BMC Biol. 2025;23(1):60. https://doi.org/10.1186/s12915-025-02173-3</mixed-citation><mixed-citation xml:lang="en">Iida K, Ajiro M, Nakano-Kobayashi A, Muramoto Y, Takenaga T, Denawa M, Kurosawa R, Noda T, Hagiwara M. Switching of OAS1 splicing isoforms overcomes SNP-derived vulnerability to SARS-CoV-2 infection. BMC Biol. 2025;23(1):60. https://doi.org/10.1186/s12915-025-02173-3</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Gokul A, Arumugam T, Ramsuran V. Genetic Ethnic Differences in Human 20-50-Oligoadenylate Synthetase and Disease Associations: A Systematic Review. Genes 2023;14:527. https://doi.org/10.3390/genes14020527</mixed-citation><mixed-citation xml:lang="en">Gokul A, Arumugam T, Ramsuran V. Genetic Ethnic Differences in Human 20-50-Oligoadenylate Synthetase and Disease Associations: A Systematic Review. Genes 2023;14:527. https://doi.org/10.3390/genes14020527</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">García-Álvarez M, Berenguer J, Jiménez-Sousa MA, Pineda-Tenor D, Aldámiz-Echevarria T, Tejerina F et al. Mx1, OAS1 and OAS2 polymorphisms are associated with the severity of liver disease in HIV/HCV-coinfected patients: A crosssectional study. Sci. Rep. 2017;7:41516.</mixed-citation><mixed-citation xml:lang="en">García-Álvarez M, Berenguer J, Jiménez-Sousa MA, Pineda-Tenor D, Aldámiz-Echevarria T, Tejerina F et al. Mx1, OAS1 and OAS2 polymorphisms are associated with the severity of liver disease in HIV/HCV-coinfected patients: A crosssectional study. Sci. Rep. 2017;7:41516.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Darbeheshti F, Mahdiannasser M, Uhal BD, Ogino S, Gupta S, Rezaei N. Interindividual immunogenic variants: Susceptibility to coronavirus, respiratory syncytial virus and influenza virus. Rev. Med. Virol. 2021;31:e2234.</mixed-citation><mixed-citation xml:lang="en">Darbeheshti F, Mahdiannasser M, Uhal BD, Ogino S, Gupta S, Rezaei N. Interindividual immunogenic variants: Susceptibility to coronavirus, respiratory syncytial virus and influenza virus. Rev. Med. Virol. 2021;31:e2234.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Zhao Y, Kang H, Ji Y, Chen X. Evaluate the relationship between polymorphisms of OAS1 gene and susceptibility to chronic hepatitis C with high resolution melting analysis. Clin. Exp. Med. 2013;13:171–176.</mixed-citation><mixed-citation xml:lang="en">Zhao Y, Kang H, Ji Y, Chen X. Evaluate the relationship between polymorphisms of OAS1 gene and susceptibility to chronic hepatitis C with high resolution melting analysis. Clin. Exp. Med. 2013;13:171–176.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Lim JK, Lisco A, McDermott DH, Huynh L, Ward JM, Johnson B et al. Genetic variation in OAS1 is a risk factor for initial infection with West Nile virus in man. PLoS Pathog. 2009;5:e1000321.</mixed-citation><mixed-citation xml:lang="en">Lim JK, Lisco A, McDermott DH, Huynh L, Ward JM, Johnson B et al. Genetic variation in OAS1 is a risk factor for initial infection with West Nile virus in man. PLoS Pathog. 2009;5:e1000321.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">El Awady MK, Anany MA, Esmat G, Zayed N, Tabll AA, Helmy A et al. Single nucleotide polymorphism at exon 7 splice acceptor site of OAS1 gene determines response of hepatitis C virus patients to interferon therapy. J. Gastroenterol. Hepatol. 2011;26:843–850.</mixed-citation><mixed-citation xml:lang="en">El Awady MK, Anany MA, Esmat G, Zayed N, Tabll AA, Helmy A et al. Single nucleotide polymorphism at exon 7 splice acceptor site of OAS1 gene determines response of hepatitis C virus patients to interferon therapy. J. Gastroenterol. Hepatol. 2011;26:843–850.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Tan Y-X, Wang H, Lv H, Liu P-P, Xia S-G, Wang Y et al. Polymorphism of OAS2 rs739901 C/A involves the susceptibility to EV71 infection in Chinese children. Curr. Med. Sci. 2018;38:640–647.</mixed-citation><mixed-citation xml:lang="en">Tan Y-X, Wang H, Lv H, Liu P-P, Xia S-G, Wang Y et al. Polymorphism of OAS2 rs739901 C/A involves the susceptibility to EV71 infection in Chinese children. Curr. Med. Sci. 2018;38:640–647.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Barkhash A, Babenko V, Kobzev V, Romaschenko A, Voevoda M. Polymorphism of 20-50-oligoadenylate synthetase (OAS) genes, associated with predisposition to severe forms of tick-borne encephalitis, in human populations of North Eurasia. Mol. Biol. 2010;44:875–882.</mixed-citation><mixed-citation xml:lang="en">Barkhash A, Babenko V, Kobzev V, Romaschenko A, Voevoda M. Polymorphism of 20-50-oligoadenylate synthetase (OAS) genes, associated with predisposition to severe forms of tick-borne encephalitis, in human populations of North Eurasia. Mol. Biol. 2010;44:875–882.</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Barkhash AV, Kochneva GV, Chub EV, Mikhailova SV, Romaschenko AG. Association between polymorphisms in OAS2 and CD209 genes and predisposition to chronic hepatitis C in Russian population. Microbes Infect. 2014;16:445–449.</mixed-citation><mixed-citation xml:lang="en">Barkhash AV, Kochneva GV, Chub EV, Mikhailova SV, Romaschenko AG. Association between polymorphisms in OAS2 and CD209 genes and predisposition to chronic hepatitis C in Russian population. Microbes Infect. 2014;16:445–449.</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Anokhin VV, Bakhteeva LB, Khasanova GR, Khaiboullina SF, Martynova EV, Tillett RL e al. Previously unidentified single nucleotide polymorphisms in HIV/AIDS cases associate with clinical parameters and disease progression. BioMed Res. Int. 2016;2016:2742648.</mixed-citation><mixed-citation xml:lang="en">Anokhin VV, Bakhteeva LB, Khasanova GR, Khaiboullina SF, Martynova EV, Tillett RL e al. Previously unidentified single nucleotide polymorphisms in HIV/AIDS cases associate with clinical parameters and disease progression. BioMed Res. Int. 2016;2016:2742648.</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Tan Y, Yang T, Liu P, Chen L, Tian Q, Guo Y et al. Association of the OAS3 rs1859330 G/A genetic polymorphism with severity of enterovirus-71 infection in Chinese Han children. Arch. Virol. 2017;162:2305–2313.</mixed-citation><mixed-citation xml:lang="en">Tan Y, Yang T, Liu P, Chen L, Tian Q, Guo Y et al. Association of the OAS3 rs1859330 G/A genetic polymorphism with severity of enterovirus-71 infection in Chinese Han children. Arch. Virol. 2017;162:2305–2313.</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Su X, Yee LJ, Im K, Rhodes SL, Tang Y, Tong X et al. Association of single nucleotide polymorphisms in interferon signaling pathway genes and interferon-stimulated genes with the response to interferon therapy for chronic hepatitis C. J. Hepatol. 2008;49:184–191.</mixed-citation><mixed-citation xml:lang="en">Su X, Yee LJ, Im K, Rhodes SL, Tang Y, Tong X et al. Association of single nucleotide polymorphisms in interferon signaling pathway genes and interferon-stimulated genes with the response to interferon therapy for chronic hepatitis C. J. Hepatol. 2008;49:184–191.</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Liao X, Xie H, Li S, Ye H, Li S, Ren K et al. 2’, 5’-Oligoadenylate Synthetase 2 (OAS2) Inhibits Zika Virus Replication through Activation of Type Ι IFN Signaling Pathway. Viruses. 2020;12(4):418. https://doi.org/10.3390/v12040418</mixed-citation><mixed-citation xml:lang="en">Liao X, Xie H, Li S, Ye H, Li S, Ren K et al. 2’, 5’-Oligoadenylate Synthetase 2 (OAS2) Inhibits Zika Virus Replication through Activation of Type Ι IFN Signaling Pathway. Viruses. 2020;12(4):418. https://doi.org/10.3390/v12040418</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Zhu H, Shang X, Terada N, Liu C. STAT3 induces antihepatitis C viral activity in liver cells. Biochem. Biophys. Res. Commun. 2004;324:518–528.</mixed-citation><mixed-citation xml:lang="en">Zhu H, Shang X, Terada N, Liu C. STAT3 induces antihepatitis C viral activity in liver cells. Biochem. Biophys. Res. Commun. 2004;324:518–528.</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Barkhash AV, Perelygin AA, Babenko VN, Myasnikova NG, Pilipenko PI, Romaschenko AG et al. Variability in the 20–50-oligoadenylate synthetase gene cluster is associated with human predisposition to tick-borne encephalitis virus-induced disease. J. Infect. Dis. 2010;202:1813–1818.</mixed-citation><mixed-citation xml:lang="en">Barkhash AV, Perelygin AA, Babenko VN, Myasnikova NG, Pilipenko PI, Romaschenko AG et al. Variability in the 20–50-oligoadenylate synthetase gene cluster is associated with human predisposition to tick-borne encephalitis virus-induced disease. J. Infect. Dis. 2010;202:1813–1818.</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Gao LJ, He ZM, Li YY et al. Role of OAS gene family in COVID-19 induced heart failure. J Transl Med. 2023;21:212. https://doi.org/10.1186/s12967-023-04058-x</mixed-citation><mixed-citation xml:lang="en">Gao LJ, He ZM, Li YY et al. Role of OAS gene family in COVID-19 induced heart failure. J Transl Med. 2023;21:212. https://doi.org/10.1186/s12967-023-04058-x</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Torices S, Teglas T, Naranjo O, Fattakhov N, Frydlova K, Cabrera R et al. Occludin regulates HIV-1 infection by modulation of the interferon stimulated OAS gene family. Mol Neurobiol. 2023;60(9):4966-4982. https://doi.org/10.1007/s12035-023-03381-0</mixed-citation><mixed-citation xml:lang="en">Torices S, Teglas T, Naranjo O, Fattakhov N, Frydlova K, Cabrera R et al. Occludin regulates HIV-1 infection by modulation of the interferon stimulated OAS gene family. Mol Neurobiol. 2023;60(9):4966-4982. https://doi.org/10.1007/s12035-023-03381-0</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Yousfi FZE, Haroun AE, Nebhani C, Belayachi J, Askander O, Fahime EE et al. Prevalence of the protective OAS1 rs10774671-G allele against severe COVID-19 in Moroccans: implications for a North African Neanderthal connection. Arch Virol. 2024;169(5):109. https://doi.org/10.1007/s00705-024-06038-y</mixed-citation><mixed-citation xml:lang="en">Yousfi FZE, Haroun AE, Nebhani C, Belayachi J, Askander O, Fahime EE et al. Prevalence of the protective OAS1 rs10774671-G allele against severe COVID-19 in Moroccans: implications for a North African Neanderthal connection. Arch Virol. 2024;169(5):109. https://doi.org/10.1007/s00705-024-06038-y</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Shcherbakova AS, Kochetkov SN, Kozlov MV. How Histone Deacetylase 3 Controls Hepcidin Expression and Hepatitis C Virus Replication. Mol Biol 2023;57:412–423 https://doi.org/10.1134/S0026893323030081</mixed-citation><mixed-citation xml:lang="en">Shcherbakova AS, Kochetkov SN, Kozlov MV. How Histone Deacetylase 3 Controls Hepcidin Expression and Hepatitis C Virus Replication. Mol Biol 2023;57:412–423 https://doi.org/10.1134/S0026893323030081</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Letchumanan P, Theva Das K. The role of genetic diversity, epigenetic regulation, and sex-based differences in HIV cure research: a comprehensive review. Epigenetics &amp; Chromatin; 2025;18: 1; https://doi.org/10.1186/s13072-024-00564-4</mixed-citation><mixed-citation xml:lang="en">Letchumanan P, Theva Das K. The role of genetic diversity, epigenetic regulation, and sex-based differences in HIV cure research: a comprehensive review. Epigenetics &amp; Chromatin; 2025;18: 1; https://doi.org/10.1186/s13072-024-00564-4</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Singh RK, Vangala R, Torne AS, Bose D and Robertson ES. Epigenetic and epitranscriptomic regulation during oncogenic -herpesvirus infection. Front. Microbiol. 2025;15:1484455. https://doi.org/10.3389/fmicb.2024.1484455</mixed-citation><mixed-citation xml:lang="en">Singh RK, Vangala R, Torne AS, Bose D and Robertson ES. Epigenetic and epitranscriptomic regulation during oncogenic γ-herpesvirus infection. Front. Microbiol. 2025;15:1484455. https://doi.org/10.3389/fmicb.2024.1484455</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Pang Y, Zhou Y, Wang Y, Fang L, Xiao S. Lactate-lactylation-HSPA6 axis promotes PRRSV replication by impairing IFN- production. J Virol. 2024;98(1):e0167023. https://doi.org/10.1128/jvi.01670-23</mixed-citation><mixed-citation xml:lang="en">Pang Y, Zhou Y, Wang Y, Fang L, Xiao S. Lactate-lactylation-HSPA6 axis promotes PRRSV replication by impairing IFN-β production. J Virol. 2024;98(1):e0167023. https://doi.org/ 10.1128/jvi.01670-23</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Ren J, Cheng S, Ren F, Gu H, Wu D, Yao X et al. Epigenetic regulation and its therapeutic potential in hepatitis B virus covalently closed circular DNA. Genes Dis. 2024;12(1):101215. https://doi.org/10.1016/j.gendis.2024.101215</mixed-citation><mixed-citation xml:lang="en">Ren J, Cheng S, Ren F, Gu H, Wu D, Yao X et al. Epigenetic regulation and its therapeutic potential in hepatitis B virus covalently closed circular DNA. Genes Dis. 2024;12(1):101215. https://doi.org/10.1016/j.gendis.2024.101215</mixed-citation></citation-alternatives></ref><ref id="cit56"><label>56</label><citation-alternatives><mixed-citation xml:lang="ru">Lefkowitz RB, Miller CM, Martinez-Caballero JD, Ramos I. Epigenetic Control of Innate Immunity: Consequences of Acute Respiratory Virus Infection. Viruses 2024;16:197. https://doi.org/10.3390/v16020197</mixed-citation><mixed-citation xml:lang="en">Lefkowitz RB, Miller CM, Martinez-Caballero JD, Ramos I. Epigenetic Control of Innate Immunity: Consequences of Acute Respiratory Virus Infection. Viruses 2024;16:197. https://doi.org/10.3390/v16020197</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
